A Bachelor's degree, equivalent to a Swedish Kandidatexamen, from an internationally recognised university. Also required is 90 credits in in one or a combination of the following subjects: pharmaceutical sciences, cell biology, biotechnology, physiology, biomedicine, chemistry, biology.
Proficiency in English equivalent to the Swedish upper secondary course English 6. This requirement can be met either by achieving the required score on an internationally recognised test, or by previous upper secondary or university studies in some countries.
Innovative therapies such as novel vaccines, immunotherapies, and gene and cell therapy are examples of strategies used in a growing field of academic research and the biotech industry. In our Master's Programme in Biopharmaceuticals, you will follow the entire life cycle of biopharmaceuticals, from design to production, testing and usage. The programme provides you with a foundation for future academic research or biotech industrial career paths. Biopharmaceuticals allow the treatment of previously difficult-to-treat targets, but the increased complexity comes with its own set of problems. The design and production of biological drugs differ from small molecular drugs, and you will study different strategies and the limitations and possibilities of these. Through the courses in this Master's programme, you will learn about: design strategies production of recombinant proteins in silico analysis of biologics pre-clinical and clinical testing regulatory approval procedures health economy The programme is run by active researchers at the Faculty of Pharmacy at Uppsala University. It is closely tied to world-renowned research groups within the field of peptide and protein drugs, pharmaceutical modulations and proteomics at Uppsala University. It is also run in collaboration with bio